Most macromolecule drugs need to be injected to provide biologic effect. Pharmaceutical companies have tried to transform injectables into convenient oral capules and tablets that overcome the absorption barrier in the intestingal tract over decades, but with limited success. Injections are associated with risk of local reaction, needle fear and pain. Biograil’s novel technology is a capsule that contains a simple and cost-efficient device for delivery of drugs into the gut wall, providing an efficient, environmental friendly and convenient option for oral drugs which otherwise needs to be injected.
Wanted field of studies